NCT01131455

Brief Summary

To compare the outcomes of patients who undergo three different types of surgeries for ankle fusion and reconstruction.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 27, 2010

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
4.4 years until next milestone

Results Posted

Study results publicly available

November 13, 2014

Completed
Last Updated

November 13, 2014

Status Verified

November 1, 2014

Enrollment Period

9 months

First QC Date

May 26, 2010

Results QC Date

July 29, 2014

Last Update Submit

November 12, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • CT Scan for Fusion Analysis

    There will be no outcome analysis for the CT scan performed on the 10 patients due to the death of the primary investigator.

    8 weeks post op.

Study Arms (3)

Fusion+ACP+Autograft

ACTIVE COMPARATOR

Standard anatomic reduction will be adhered to- neutral alignment will be employed (5° valgus, external rotation and neutral foot dorsiflexion). The arthrodesis undertaken for all groups will be the standard arthroscopic ankle arthrodesis with portals to the ankle (anterior medial / anterior lateral), skin incision only technique with dissection through the capsule and penetration to the joint. Standard debridement of the gutters, tibia osteophyte, tibia-talor joint resection and autograft preparation will be performed in the joint. Depending on randomization of the subject, (Autologous concentrated Plasma)ACP-A or ACP-DBM mixture will be added to the arthrodesis site with the joint taken through range of direct motion and reduced.

Biological: Autologous Concentrated Plasma

Fusion + ACP +DBM

ACTIVE COMPARATOR

Standard anatomic reduction will be adhered to- neutral alignment will be employed (5° valgus and external rotation and neutral foot dorsiflexion). Depending on the randomization of the subject, (Autologous Concentrated Plasma)ACP-A or ACP-DBM mixture will be added to the arthrodesis site with the joint taken through range of direct motion and then reduced.

Biological: Autologous Concentrated Plasma

Standard-Fusion +Autograft only

NO INTERVENTION

Standard anatomic reduction will be adhered to- neutral alignment will be employed (5° valgus and external rotation and neutral foot dorsiflexion). The arthrodesis undertaken for all groups will be the standard arthroscopic ankle arthrodesis with portals to the ankle (anterior medial / anterior lateral), skin incision only technique with blunt dissection through the capsule and penetration to the joint. Depending on the randomization of the subject, ACP-A or ACP-DBM mixture will be added to the arthrodesis site with the joint taken through range of direct motion and then reduced.

Interventions

Autologous blood products have created a growing interest for use in a number of orthopedic therapies. The healing effects of plasma are supported by growth factors released by platelets. These growth factors induce a healing process wherever they are applied. The Arthrex ACP System is a cost-effective method of concentrating growth factors for therapeutic use.

Also known as: ACP
Fusion + ACP +DBMFusion+ACP+Autograft

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients whom present the need for the elective surgery

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia Orthopedic Group

Columbia, Missouri, 65201, United States

Location

Results Point of Contact

Title
Vicki L Jones, Research Coordinator
Organization
ColumbiaOG

Study Officials

  • Paul Shurnas

    Columbia Orthopaedic Group

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sr. Research Coordinator

Study Record Dates

First Submitted

May 26, 2010

First Posted

May 27, 2010

Study Start

October 1, 2009

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

November 13, 2014

Results First Posted

November 13, 2014

Record last verified: 2014-11

Locations